EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.
4 Growth Stocks From the Insurance Space to Add to Your Portfolio
Given the prospects of the insurance industry, EVER, HMN, ROOT and HCI have the potential to generate better returns than other players.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
Add INTU, NVMI, EVER and SEZL to your watchlist as each boasts strong liquidity, growth attributes and operational efficiency.
Wall Street Analysts See a 38.85% Upside in EverQuote (EVER): Can the Stock Really Move This High?
The mean of analysts' price targets for EverQuote (EVER) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
EverQuote (EVER) Up 4.8% Since Last Earnings Report: Can It Continue?
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock?
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
Boost returns with liquid, efficient top-ranked stocks like NEM, PGY, EVER and SEZL, each of which is backed by strong growth and financial metrics.
Wall Street Analysts Think EverQuote (EVER) Could Surge 42.43%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 42.4% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
EverQuote: Stock With Above-Average Gain Potential
EverQuote's technology efficiently matches pre-validated consumers with insurance providers, optimizing marketing spend and ROI for insurers. The fragmented P&C insurance market presents a significant growth opportunity for the Company, addressing inefficiencies in consumer-provider matching and advertising channels. EVER's above-average growth can drive strong annual stock gains from the reasonable valuation level.
